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The burden of cancer at work: estimation as the first
step to prevention
L Rushton,1 S Hutchings,1 T Brown2
ABSTRACT
Objectives: Work-related cancers are largely preventa-
ble. The overall aim of this project is to estimate the
current burden of cancer in Great Britain attributable to
occupational factors, and identify carcinogenic agents,
industries and occupations for targeting risk prevention.
Methods: Attributable fractions and numbers were
estimated for mortality and incidence for bladder, lung,
non-melanoma skin, and sinonasal cancers, leukaemia
and mesothelioma for agents and occupations classified
as International Agency for Research on Cancer (IARC)
Group 1 and 2A carcinogens with “strong” or “sugges-
tive” evidence for carcinogenicity at the specific cancer
site in humans. Risk estimates were obtained from
published literature and national data sources used for
estimating proportions exposed.
Results: In 2004, 78 237 men and 71 666 women died
from cancer in Great Britain. Of these, 7317 (4.9%) deaths
(men: 6259 (8%); women: 1058 (1.5%)) were estimated
to be attributable to work-related carcinogens for the six
cancers assessed. Incidence estimates were 13 338
(4.0%) registrations (men: 11 284 (6.7%); women 2054
(1.2%)). Asbestos contributed over half the occupational
attributable deaths, followed by silica, diesel engine
exhaust, radon, work as a painter, mineral oils in metal
workers and in the printing industry, environmental
tobacco smoke (non-smokers), work as a welder and
dioxins. Occupational exposure to solar radiation, mineral
oils and coal tars/pitches contributed 2557, 1867 and 550
skin cancer registrations, respectively. Industries/occupa-
tions with large numbers of deaths and/or registrations
include construction, metal working, personal and
household services, mining (not metals), land transport
and services allied to transport, roofing, road repair/
construction, printing, farming, the Armed Forces, some
other service industry sectors and manufacture of
transport equipment, fabricated metal products, machin-
ery, non-ferrous metals and metal products, and
chemicals.
Conclusions: Estimates for all but leukaemia are greater
than those currently used in UK health and safety strategy
planning and contrast with small numbers (200–240
annually) from occupational accidents. Sources of
uncertainty in the estimates arise principally from
approximate data and methodological issues. On balance,
the estimates are likely to be a conservative estimate of
the true risk. Long latency means that past high
exposures will continue to give substantial numbers in the
near future. Although levels of many exposures have
reduced, recent measurements of others, such as wood
dust and respirable quartz, show continuing high levels.
There is increasing interest in estimating and
comparing burdens of disease generally1 and for
cancer.2 3 Estimates can identify major risk factors
and high-risk populations, support decisions on
priority actions for risk reduction and provide an
understanding of important contributions to
health inequalities. Nearly 30 years ago Doll and
Peto (1981), in their report to the US Congress,
presented a method of estimating the effects of
different factors on cancer mortality in the USA4;
their estimate for occupational factors was 4% of
all US cancer deaths with an uncertainty range of
2%–8%. The aim of this project is to produce an
updated and detailed estimate of the current
burden of occupational cancer in Great Britain
(GB) that will help to inform the development and
prioritisation of practical measures to reduce the
burden in the future, specifically in GB, but also
more generally in the developed world. The
estimates of current burden of occupational cancer
are based on exposure levels from up to 50 years
ago when exposure levels may have been much
higher than they are at present. Prioritisation for
preventive effort requires consideration of ongoing
risks and current exposures. The next phase of the
project will include predictions of future burden
based on current exposure levels.
In this paper the outcomes of the first phase of
the project are presented. Estimates have been
made of the current burden due to past occupa-
tional exposures for six cancers, which are impor-
tant in terms of both the annual numbers of deaths
and cancer registrations they produce and their
potential to be caused by exposure to occupational
carcinogens. The six are cancer of the bladder;
leukaemia; cancer of the lung, mesothelioma; non-
melanoma skin cancer (NMSC) and sinonasal
cancer. An overview of the methodology developed
and the data used is also given.
METHODS
Occupational carcinogens assessed
At two international workshops held as part of the
project to discuss the methodology (http://www.
hse.gov.uk/research/hsl_pdf/2005/hsl0554.pdf;
http://www.hse.gov.uk/research/hsl_pdf/2007/
hsl0732.pdf) the participants advised that priority
should be given initially to International Agency
for Research on Cancer (IARC) Group 1 and 2A
occupationally related carcinogens. Agents or
occupations in these IARC groups were included
that had either “strong” or “suggestive” evidence
of carcinogenicity in humans for the specific cancer
site, as defined by Siemiatycki et al (2004) and
subsequent IARC publications.57 Those with
“strong”evidenceweredefinedas“established”carcinogensforthepurposesofthisstudyand
those with “suggestive” evidence of carcinogeni-
ci ty in humans were defined as “u n c e r t a in”
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carcinogens. In addition there had to be substantial existing
exposures in GB and/or cases of cancer still occurring due to
past exposures.
Data sources
(i ) Cancer mortal i ty and registration data
Estimation was carried out on a cancer by cancer basis for 2004
for mortality and 2003 for cancer incidence, the most recent
years for which published data were available at the time of
estimation. Deaths for 2005 and cancer registrations for 2004
are now available but total numbers do not differ substantially
from those used. Mortality data were obtained from ONS,
Mortality Statistics, Series DH2, for England and Wales and the
General Register Office for Scotland. Cancer incidence data
were obtained from ONS, Cancer Statistics, Registrations,
Series MB1 for England, the Scottish Cancer Registry, (http://
www.isdscotland.org/isd) and the Welsh Cancer Intelligence
and Surveillance Unit (http://www.wales.nhs.uk/sites3/home.
cfm?OrgID = 242).
(i i )Risk es t imates
Standard search criteria were used to identify key studies, meta-
analyses or pooled studies, taking into account relevance to GB,
large sample size, effective control for confounders, adequate
exposure assessment, and clear case definition. Where only a
narrative review was available giving a range of risk estimates
from several relevant studies a combined estimate of the relative
risks (RRs) was calculated based on a random- (for hetero-
geneous RRs) or fixed- (for homogeneous RRs) effects model. If
no meta-analysis, pooled study or narrative review were
available a single key study was selected using the criteria
above. Dose-response risk estimates were generally not avail-
able, nor were proportions of those exposed at different levels of
exposure over time available for the working population in GB.
In our study separate risk estimates were generally extracted
relating to an overall “higher” level and an overall “lower” level.
For one or two specific agents it was possible to extract risk
estimates for three levels of exposure or for specific exposure
scenarios (see table 2 footnotes). Where no estimate could be
identified for very low/background/environmental levels of
exposure, an RR of one was arbitrarily assigned.
( i i i ) Exposed populat ion est imates
If the relative risks were extracted from an industry-based study
population, for example a cohort study, a national (external)
data source was used for estimating the proportion of the
population exposed. If the relative risks were extracted from a
population-based study, for example a case-control study of
cancer registry cases, an estimate of the proportion of cases
exposed was also obtained from the study, although such
studies were rarely available for GB. The national data sources
used were the CARcinogen EXposure (CAREX) database,8 and
for exposures not covered by CAREX, the annual Labour Force
Survey (LFS) (http://www.statistics.gov.uk/) and the Census of
Employment (CoE) (https://www.nomisweb.co.uk/). Data
from CAREX are not differentiated by sex; 1991 Census data
by industry and occupation were used to estimate the relative
proportions of men and women exposed (http://cdu.mimas.ac.
uk). The industry categories listed in CAREX were allocated to
“higher” and “lower” exposure categories assuming the
distributions of levels of exposure and risks associated with
these broadly matched those of the studies from which RRs
were extracted.
Statistical analysis
The attributable fraction (AF), that is the proportion of cases
that would not have occurred in the absence of exposure, has
been estimated. There are two principal methods for estimating
the AF, both of which depend on knowledge of the risk of the
disease due to the exposure of interest and the proportion of the
population exposed.9
To estimate the AFs for each cancer/occupational carcinogen
Levin’s equation10 was used if risk estimates came from an
industry-based study, review or meta-analysis together with
estimates of the proportion of the population exposed from
independent sources of data. Miettinen’s equation was used if
risk estimates and proportion of cases exposed came from a
population-based study.11 The equations used are given in the
Statistical Appendix. The AFs were applied to total numbers of
cancer-specific deaths (2004) and cancer registrations (2003) to
give attributable numbers. Where AFs were only available for
mortality these were used for estimation of attributable
registrations and vice versa. Similarly if separate AFs for women
could not be estimated those for men or for men and women
combined were used.
To take account of cancer latency a “relevant exposure
period” (REP) was defined as the period during which exposure
occurred that was relevant to the development of the cancer in
the target year 2004. For solid tumours a latency of at least
10 years and at most 50 years was assumed giving an REP of
1955–1994. For haematopoietic neoplasms 0–20 years latency
was assumed giving an REP of 1985–2004. The proportion of the
GB population exposed to the occupational carcinogens of
concern over the REP was estimated taking into account
changes in numbers employed in the primary and manufactur-
ing industry and service sectors in GB over the REP. Figures
from the LFS show, for example, that the numbers of men
employed in primary and manufacturing industry were 40%
higher in the 1970s than they were in the early 1990s, whereas
the numbers employed in the service industries were 10% lower.
Adjustment for employment turnover over the period for
grouped main industry sectors was also carried out using LFS
data on the distribution of length of time with current employer
(in excess of 1 year) by length of employment. This gave the
numbers ever employed for at least 1 year during the REP
allowing for normal life expectancy to 2004 (see Statistical
Appendix equation 3). The adjustment factors for changing
employment levels and percentage annual turnovers used are
shown in the table in the Statistical Appendix.
The AF for mesothelioma was derived directly from several
studies of UK mesothelioma cases that suggest that between
85% and 90% of male mesothel ioma cases are due to
occupational exposure12 13 (Darnton, personal communication).
Studies in which results were reported separately for females in
the UK (Darnton, personal communication) and elsewhere14 15
gave estimates of 20%–30%. For the estimate of the AF due to
the “Established plus Uncertain carcinogens”, cases described as
due to paraoccupational (eg, exposure from living near an
asbestos factory or handling clothes contaminated due to
occupational exposure) or environmental exposure to asbestos
are also included.
A recent analysis of lung cancer mortality for the whole of GB
between 1980 and 2000 by occupational group in relation to
indices of asbestos exposure and smoking habits suggested that
the ratio of asbestos-related lung cancer to mesothelioma deaths
is between two-thirds and one.16 A ratio of 1:1, mesothelioma to
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For lung cancer associated with radon exposure from natural
sources, estimates of rates of lung cancer due to exposure to
radon in domestic buildings were applied to estimates of the
time employees spend in workplaces where radon exposure
occurs.
AFs for all the relevant carcinogenic agents and occupational
circumstances were combined into a single estimate of AF for
each separate cancer. AFs in general cannot be summed directly
if there is a possibility that workers will have been exposed to
more than one occupational carcinogen during their working
lifetimes in the relevant exposure period. Where data allowed,
the exposed numbers were therefore partitioned between
overlapping exposures, for example by excluding steel foundry
workers from the CAREX estimates of numbers exposed to
other lung carcinogens. Alternatively, where exposure to more
than one carcinogen associated with the same cancer site
occurred,anAFwasestimatedonlyforthe“dominant”carcinogenwiththehighestriskestimate.Themethodof
combining the AFs was then determined by whether there was
residual exposure to multiple carcinogens. If so, it was assumed
that the exposures were independent of one another and that
their joint carcinogenic effects were multiplicative. Such multi-
ple/overlapping exposures were assigned to exposure sets that
were judged to be non-overlapping with other exposure sets and
single exposure scenarios. The AFs within exposure sets were
multiplied using equation 5 in the Statistical Appendix. The
combined AFs for each non-overlapping exposure set were then
summed, together with non-overlapping single exposures.
An overall AF for occupation for the six cancers assessed so far
was estimated by summing the attributable numbers for the six
cancers and dividing by the total number of cancers in GB
(table 1).
Although it is relatively straightforward to estimate a
confidence interval for AFs of single carcinogenic agents,9 the
methodology for estimating confidence intervals for AFs
estimated from more than one risk estimate for multiple
exposure levels and for combinations of AFs is more complex,
for example requiring Monte Carlo methods. The methodology
for this is currently under development and confidence limits
are not presented.
Separate technical reports for each cancer giving full details of
data and calculations, and a report expanding on the statistical
methodology are accessible at http://www.hse.gov.uk/research/
rrhtm/rr595.htm.
RESULTS
The overall occupational AFs for the six cancers investigated so
far are summarised in table 1. Six per cent (n = 4693) of cancer
deaths in 2004 in men and 1.0% (n = 701) in women in GB have
been estimated to be due to occupation for carcinogens with
stronghumanevidenceofcarcinogenicity,our“established”carcinogens.Theestimateswere4.9%(7317deaths)intotal,
8.0% for men (6259 deaths) and 1.5% for women (1058 deaths),
for carcinogens with strong or suggestive evidence of carcino-
genicity in humans, our “established plus uncertain” carcino-
gens.
The combined AFs for registrations are 6.7% (n = 11 284) for
men in 2003 and 1.2% (n = 2054) for women based on
established and uncertain carcinogens. These are lower than
that for deaths because of the very large numbers for NMSC.
Table 2 gives the number of deaths for each cancer
attributable to each of the agents and occupations considered
(so far) for established and uncertain carcinogens together. The
studies that were used for the risk estimates for each agent or
occupation and the type of study are also given in table 2.
Overall, asbestos exposure contributes the largest number of
deaths (mesothelioma and lung cancer), followed by exposure
to silica (lung), diesel engine exhaust (DEE) (lung, bladder),
radon exposure from natural exposure in workplaces (lung),
occupation as a painter (lung, bladder), mineral oils in metal
workers (bladder, sinonasal, NMSC), environmental tobacco
smoke (ETS) in non-smokers (lung), mineral oils in printers
(lung), occupation as a welder (lung) and exposure to dioxins
(lung).
For the six cancers, exposures in the construction industry are
estimated to produce over half of GB’s occupational attributable
cancer deaths in men (n = 3219). Workers in this industry are
exposed to 17 of the carcinogens considered so far (13 resulting
in at least one death), shown in fig 1 for men, who account for
an estimated 99% of the construction workforce in the REPs for
these cancers.
There are 44 deaths for NMSC attributable to occupational
exposure to mineral oils, polycyclic aromatic hydrocarbons
(PAHs) and solar radiation. However, estimated numbers of
registrations for NMSC associated with mineral oils are 1745
males (M), 122 females (F), with PAHs; mainly coal tars and
pitches are 547 M (544 in construction), 3 F; and with solar
radiation are 1824 M (805 in construction), 733 F.
Table 3 gives for each cancer, numbers of deaths (registrations
for NMSC) within industry sectors or jobs for which there were
at least 50 estimated attributable cancers; the exposures
concerned are listed, with those contributing most (at least 10
cancers in men plus women) being shown in bold. Painters and
welders are assumed to be exposed to many different carcino-
gens. The importance of single exposures within some industry
sectors is also highlighted, for example PAHs in coal tar and
pitches in roofing and road repair and construction, metal
working fluids in the metal industries, mineral oils and printing
inks in the printing industry. In addition to the construction
industry table 3 shows that multiple exposures potentially
occur in several other industries, including the manufacture of
industrial chemicals (18, notably asbestos) and other chemical
products (16, also notably asbestos), manufacture of transport
equipment (15, particularly asbestos, chromium, cobalt, silica,
radon and solar radiation), electricity, gas and steam (15,
notably asbestos and solar radiation), non-ferrous metal basic
industries (14, notably arsenic), the manufacture of fabricated
metal products (14, notably cobalt, chromium and silica), the
manufacture of machinery except electrical (13, notably silica,
chromium, cobalt and radon), services allied to transport (13,
notably DEE and solar radiation), and printing, publishing and
allied industries (12, notably solar radiation). More than 10
different exposures were also found in sanitary and similar
services (14, notably solar radiation and asbestos), personal and
household services (11, notably asbestos, diesel engine exhaust,
ETS and radon), and land transport (11, notably DEE, asbestos
and solar radiation).
Table 3 also highlights the range of industry sectors where
particular substances are occurring and contributing to the
burden of occupational cancer. These sectors are not always
those where substantial historical exposures have occurred. For
example, the main occupations with substantial historical
exposure to inorganic arsenic include hot copper smelting,
manufacturing of arsenical pesticides and sheep-dip compounds,
fur handlers and vineyard workers and some miners.63 64 In GB
the majority of exposure occurs in the non-ferrous metal basic
industry and the manufacture of wood and wood and cork
products (44 and 31 lung cancer deaths, respectively).
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Table 1 Estimated attributable fractions, deaths and registrations by cancer site in 2004 (2003 for
registrations)
Attr ibutable numbers
Attributable fraction (%) Deaths Registrations
Cancer site Male Female Total Male Female Male Female
(a) Establ ished carcinogens only (IARC Group 1, strong human evidence)
Bladder 1.3 0.6 1.0 40 10 89 17
Leukaemia 0.3 0.5 0.2 4 5 5 6
Lung 16.5 4.5 11.6 3137 599 3509 680
Mesothelioma 85–90 20–30 74–80 1450 75 1450t 75t
NMSC 11.8 3.0 8.4 38 6 3992 855
Sinonasal 34.1 10.8 23.4 24 6 74 18
Total
Based on deaths 6.0 1.0 3.6 4693 701
Based on registrations 5.4 1.0 3.2 9120 1652
(b) Established + uncertain carcinogens (IARC Group 1 and 2A, strong + suggestive human evidence)
Bladder 11.6 2.0 8.3 362 32 816 57
Leukaemia 2.7 0.8 1.7 58 11 93 15
Lung 21.6 5.5 15.0 4106 728 4594 826
Mesothelioma 98* 90* 97* 1650 270 1650t 270t
NMSC 11.8 3.0 8.4 38 6 3992 855
Sinonasal 64.3 18.4 43.3 45 11 140 31
Total:
Based on deaths 8.0 1.5 4.9 6259 1058
Based on registrations 6.7 1.2 4.0 11 284 2054
Total cancers in GB 78 237 71 666 167 506 164 586
includes cases described as due to paraoccupational or environmental exposure to asbestos.
tTaken as equal to attributable deaths for this short-survival cancer.
Mid-points of ranges used when estimating attributable numbers and combining results for mesothelioma with the other cancers.
GB, Great Britain; IARC, International Agency for Research on Cancer; NMSC, non-melanoma skin cancer.
Although potential asbestos exposure occurred in large
numbers of workers (over 65 000 in the REP) in the mining
industry (excluding coal mining) giving 305 deaths each from
lung cancer and mesothelioma in men, the industry with the
greatest potential for asbestos exposure was the construction
industry, occurring for example in asbestos removal or stripping,
giving 1012 deaths each from lung cancer and mesothelioma in
men. In personal and household services, 362 deaths each from
lung cancer and mesothelioma occurred (221 each of these in
women). Other industry groups where asbestos exposure
contributed to fairly large numbers of deaths in men for both
lung cancer and mesothelioma were work in land transport45
and manufacture of transport equipment.39
Other substances occurring across several industry sectors
that contributed substantially to the burden of cancer are listed
below.
Diesel engine exhaust
In addition to 21 male bladder cancer deaths and a total of 268
lung cancer deaths attributed to exposure to DEE in the land
transport industry where over 600 000 workers were estimated
to be potentially exposed over the REP, an additional half a
million workers were exposed to DEE over the REP in the
construction industry giving 20 male bladder cancer deaths and
238 male lung cancer deaths.
ETS (non-smokers)
Significant numbers of workers were exposed to ETS in the
wholesale and retail trade, restaurants and hotels, construction,
and financing, insurance, real estate and business services giving
104, 35 and 29 lung cancer deaths, respectively.
Radon
There are now very few workers in metal ore mining in the UK
exposed to radioactive radon and its progeny. High levels of
radon in the workplace occur in similar areas to those of concern
in residential dwellings in the UK such as Cornwall, Devon
Northamptonshire and parts of Derbyshire, Somerset, Wales,
Grampian and the Highlands of Scotland. Approximately 2000
lung cancer deaths a year have been estimated to be due to
radon exposure of which between about 90 and 275 are
attributable to exposure occurring in the workplace.55
Although any workplace in the affected areas is potentially at
risk of exposure, the large numbers of workers employed in the
wholesale and retail trade, restaurants and hotels, and in
finance, insurance, real estate and business services gave
relatively high estimated numbers of lung cancer deaths — 75
and 47, respectively.
Silica
In GB the majority of workers exposed to silica work in the
construction industry, manufacture of other non-metallic
mineral products and manufacture of pottery, china and
earthenware giving an estimated 667, 28 and 25 deaths of
men in these industries, respectively.
Solar radiation
The risk for NMSC caused by occupational exposure to solar
radiation is difficult to estimate because everyone is exposed to
sunlight to a greater or lesser degree depending on residential
location and leisure time activities. Risk estimates from a US-
based case-control study of 6565 cases of NMSC were used that
estimated separate risks for work that combined indoor and
outdoor work, outdoor work by non-farmers and farming.58
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Figure 1 Lung cancer deaths for men in
2004 attributable to work in the
construction industry. ETS, environmental
tobacco smoke; PAH, polycyclic aromatic
hydrocarbon.
Large numbers of registrations were estimated for the construc-
tion industry (860), public administration and defence (armed
forces) (232), wholesale and retail trade, restaurants and hotels
(168), land transport (166), manufacture of transport equip-
ment (154), agriculture and hunting (143) and communication
(132).
A table giving industry sectors and occupations with at least
10 attributable deaths and/or registrations for each of the six
cancer sites assessed so far (50 registrations for NMSC) by
occupational exposure is given in a supplementary table online.
DISCUSSION
All occupational cancers are potentially avoidable. Our estimate
of the current burden in 2004 of six cancers due to past
occupational exposures of 8% for men and 1.5% for women
translates to over 7300 cancer deaths in GB. This is in contrast
to the 223 deaths due to occupational injuries that occurred that
year (http://www.hse.gov.uk/statistics/overall/fatl0506.pdf).
Burden estimates from other studies range between 3% and
10%.65–72 With the exception of leukaemia, all our updated
estimates are greater than those of Doll and Peto (1981).4 The
steep rise in asbestos-related deaths from lung cancer and
mesothelioma since 1981 has made a major contribution to the
increase.16 73
Our methodology and the data available in GB have allowed a
more detailed investigation of the carcinogenic agents, occupa-
tional circumstances and industry sectors than has been possible
in other burden estimation studies. We have also addressed the
potential to be exposed to several carcinogens concurrently and
the impact on total burden.
The results must be considered taking account of several
uncertainties and limitations. These are discussed below and the
potential impact on the estimates is indicated in table 4.
Agents classified by IARC as Group 1 and 2A carcinogens
were assessed. Other substances such as IARC Group 2B
carcinogens, many of which may be treated as if they were
human carcinogens in regulatory settings have not yet been
evaluated; our estimates could thus be too low.
Uncertainty or bias may have been introduced in the choice of
the study for obtaining data for the risk estimates, for example
if the exposures in the source study did not reflect those
experienced in GB or distributions of confounders differed
between the source population and GB. A major gap in available
information was a lack of separate risk estimates for women
and/or cancer incidence. The use of risk estimates derived from
studies of men for women and mortality risk estimates for
incidence may have biased the AFs. Epidemiological studies of
occupational groups often result in a “healthy worker effect”,
that is a reduced overall risk estimate compared to the general
population. This together with potential misclassification of
exposure in epidemiological studies could lead to an under-
estimation of the true effect and thus an underestimation of the
burden.
Most of the risk estimates from the published literature were
related to some estimate of cumulative exposure. In assigning
“higher” and “lower” categories to the CAREX industry groups
implicit assumptions were made regarding the similarity of
durations and intensities of exposure between the source and
target (national) populations. National data are not generally
available on the proportions of those exposed at different levels
of exposure.
Where no risk estimate could be identified for very low/
background/environmental levels of exposure, a risk estimate of
one was arbitrarily assigned to the “lower” group, giving a zero
attributable burden. This implies an assumption that a thresh-
old existed in the dose relationship between exposure and effect
contrary to usual risk assessment guidelines for carcinogens; this
may have contributed to underestimation of the burden; a large
number of people exposed at low levels associated with a low
risk of disease may contribute more to the burden than a small
number exposed at high levels associated with a high risk.
In most occupational epidemiological studies very short-term
workers, for example those employed for less than 1 year, are
excluded. Our turnover factor was thus calculated excluding
workers with less than 1 year’s employment. Inclusion of these
would have increased the numbers ever exposed considerably.
For example, for the construction industry, the annual turnover
would increase from 13% excluding workers with under 1 year
of employment to 22% when they are included. The overall
effect of including these short-term workers would be to
increase the AFs and attributable numbers. However, when
these short-term workers are excluded the turnover factor
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Table 3 Industry sectors and occupations with an estimate of a total of at least 50 attributable deaths (registrations for NMSC) by cancer site and
occupational exposure
Attr ibutable deaths (regis trat ions for NMSC)
Bladder Leukaemia Lung Mesothelioma NMSC Sinonasal Total *
Industry/job categories M F M F M F M F M F M F M F Exposures
Construction including: 47 0 0 0 2132 10 1012 1336 58 15 0 4543 69 Ar, Asb, Ch, Co, DEE, ETS,
Pb, PAH, R, Si, Sr, W, Ca,
N, Fo, PAHc , ‘ ‘painting”
Roofers, glaziers,
road surfacers,
concreters,
roadman, paviours,
kerb layers and
their foremen
544 3 544 3 PAHc
Painters & decorators 27 0 201 2 228 2 ‘‘painting”Metal workers 243 13 1745 122 20
2 2008 137 MWF
Personal and household 0 0 1 0 170 240 141 221 6 7 317 468 Asb,Ca,Bz,DEE,ETS,PAH,
services R, Sr, Ch, Pb, Fo
Mining (not metals) 2 1 347 15 305 20 11 674 27 Asb, DEE, PAH, Si, Sr
Land transport 21 2 0 0 288 30 45 77 89 431 121 Asb, Bz, DEE, ETS, PAH, R,
Sr, Ch, Pb, Si, W
Wholesale and retai l t rade
and restaurants and hotels
Printers and printing machine
minders and their foremen
Printing, publishing and allied
industries
Farming, horticulture,
gardening, forestry and related
Manufacture of transport
equipment
Public administration and
defence (Armed Forces)
0 0 100 110 26 78 90 204 200 Asb, Bz, DEE, ETS, PAH, R,
Sr, Pb
195 40 195 40 mineral oils + printing ink
7 3 58 32 65 35 Ca, Co, DEE, Pb, PAH, R, Sr,
Ch, ETS, Ni, Si, W
15 3 110 11 114 29 239 43 D, NAP, Sr, R, ETS
3 71 11 39 100 54 1 214 65 Ar, Asb, Be, Ch, Co, DEE,
N, PAH, R, Si, Sr, Ca, ETS,
Pb, W
19 22 215 17 234 39 R, ETS, PAH, DEE, Sr, Pb
Services allied to transport 2 0 0 0 26 6 61 71 89 77 Bz, Co, DEE, ETS, Pb, PAH,
R, Sr, Ca, Ch, N, Si, W
Welders 139 13 139 13 ‘ ‘Welding fumes”
Financing, insurance, real 27 25 46 53 73 78 R, ETS, Sr
estate and business services
Communication 7 6 61 71 68 77 DEE, ETS, R, Sr, Pb
Manufacture of fabricated 2 0 0 61 21 16 9 1 1 80 31 Be, Ca, Co, Ch, Fo, DEE, Pb,
metal products, except N, PAH, R, Si, Sr, ETS, W
machinery and equipment
Sanitary and similar services 0 0 9 13 5 8 30 35 44 56 Ar, Asb, Bz, Co, DEE, ETS,
PAH, R, Sr, Ca, Ch, Pb, Si,
W
Electricity, gas and steam 2 16 3 7 33 18 58 21 Ar, Asb, Be, Ch, Co, DEE,
PAH, R, Si, Sr, Ca, ETS, Pb,
N, W
1 0 0 57 20 58 20 Be, Ca, Ch, Co, DEE, PAH,
R, Si, Fo, ETS, Pb, N, W
1 0 0 53 15 6 3 0 0 60 18 Ar, Bz, Ca, Ch, Co, DEE, Pb,
N, PAH, R, Si, Sr, Fo, W
0 0 4 1 6 2 3 6 4 6 A r , B z , E O , 1 – 3 B , A s b , C h ,
Co, DEE, Pb, R, Si, Fo, Ca,
ETS, N, W
5 0 44 15 49 15 ‘ ‘Spray painting”
7 8 24 28 31 36 Ar, ETS, R, Sr
0 0 0 0 36 5 22 58 5 Ar, AA, Asb, Bz, Fo, 1–3B,
Ca, Ch, Co, DEE, Pb, PAH, R,
Si, Be, ETS, N, W
Table 3 gives for each cancer, numbers of deaths (registrations for NMSC) within industry sectors or jobs for which there were at least 50 estimated
attributable cancers; the exposures concerned are listed, with those contributing most (at least 10 cancers in men plus women) being shown in bold.
*Totals are for lung, bladder , leukaemia, mesothel ioma and nasal cancers plus attr ibutable registrations for NMSC. 0 = ,0.5; blank cel l = cancer
not represented.
AA, aromatic amine (bladder); Ar, arsenic (lung); Asb, asbestos (lung, mesothelioma); Be, beryllium (lung); Bz, benzene (leukaemia); Ca, cadmium (lung); Ch, chromium IV (lung,
sinonasal); Co, cobalt (lung); D, dioxins (lung); DEE, diesel engine exhaust (lung, bladder); EO, ethylene oxide (leukaemia); ETS, environmental tobacco smoke (lung); F, female; Fo,
formaldehyde (sinonasal, leukaemia); M, male; MWF, metal working fluids (bladder, NMSC, sinonasal); N, nickel (lung, sinonasal); NAP, non-arsenical pesticide (leukaemia); NMSC,
non-melanoma skin cancer; PAH, polycyclic aromatic hydrocarbon (lung, bladder); PAHc, coal tar and pitch (NMSC); Pb, lead (lung); R, radon (lung); Si, silica (lung); Sr, solar
radiation (NMSC); W, wood dust (Sinonasal); 1–3B 1–3 butadiene (leukaemia).
Manufacture of machinery
except electrical
Non-ferrous metal basic
industries
Manufacture of other
chemical products
Coach and other spray
painters and painting
assembling and related
occupations
Recreational and cultural
services
Manufacture of industrial
chemicals
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estimates are similar to those used in the Global Burden of
Disease project.66
There was a general lack of information on the latency of the
cancers, particularly in relation to specific occupational expo-
sures. The assumptions made in the study have influenced the
numbers ever exposed giving high estimates in some cases. In
particular a uniform distribution of cancer induction between
the maximum and minimum latency was assumed, although
reality may be a distribution that peaks in the early 1970s and
tails off towards more recent periods.
In combining the AFs for different risk factors, multiple
exposures and other non-occupational risk factors were
considered. Cancer is a multifactorial and multistage disease
that may not be due to any single sufficient cause but rather a
sequence of “hits” over a life course. For example, smoking
alone may not be sufficient to cause lung cancer and those who
get it are likely to have been exposed to several lung carcinogens
and possess other characteristics such as some form of inherited
susceptibility. The mathematical implication of this is that the
sum of attributable fractions for several exposures may be
greater than 100%, with the amount exceeding 100% being
partly due to synergistic interactions among the risk factors.74
We have avoided this problem of “double counting” of the
interactions to some extent by partitioning exposed worker
populations between overlapping carcinogenic exposures before
estimating AFs. In other cases where overlap remains we have
assumed risks are multiplicative, so that the combined AF
incorporates the interaction between exposures.
Many past exposures will have been at much higher levels
than those existing today. However, trends vary depending on
the substance and source of data. For example, analyses of
exposure measurement data held in the National Exposure
Database (NEDB) and from Health and Safety Executive (HSE)
inspection surveys and other surveys showed downward trends
of 11% per year for toluene between 1985 and 2002 based on
inspection surveys but follow-up surveys of eight companies
using toluene-containing compounds show an average decrease
of only 1% per year in toluene concentrations.75 Although
respirable dust exposure in the quarry industry declined by 6%
each year from 1984 to 2003 there was no clear change in
exposure over time for respirable quartz exposure.
Other exposures have all but disappeared due to the decline of
the industry or the substitution of hazardous substances by
Table 4 Uncertainties and limitations of the methodology and their
potential impact on the estimate of the burden of disease due to
occupation
Potential impact
on burden
Source of uncertainty estimate
Exclusion of IARC Group 2B and unknown carcinogens Q
Inappropriate choice of source study for risk estimate IQ
Imprecision in source risk estimate IQ
Source risk estimate from study of highly exposed workers applied I
to lower exposed target population
Risk estimate biased down by healthy worker effect, exposure Q
misclassification in both study and reference population
Use of RR = 1 for very low/background/environmental levels of Q
exposure where no value available from literature
Inaccurate risk-exposure period IQ
Unknown proportion exposed at different levels of exposure IQ
Effect of unmeasured confounders IQ
Use of Levin’s formula when RR adjusted for confounders Q
IARC, International Agency for Research on Cancer; RR, relative risk. Main
messages
c Overall, 4.9% (8% men, 1.5% women) of all cancer deaths in
Great Britain in 2004 were attributable to work-related
carcinogens (based on the assessment of six cancers and
International Agency for Research on Cancer Group 1 and 2A
carcinogens with strong or suggestive human evidence).
c Asbestos contributed over half the occupational attributable
deaths, followed by silica, diesel engine exhaust, radon, work
as a painter, mineral oils in metal workers and in the printing
industry, environmental tobacco smoke (non-smokers), work
as a welder and dioxins.
c Occupational exposure to solar radiation, mineral oils and coal
tars/pitches contributed large numbers of skin cancer
registrations.
c Industries/occupations with large numbers of cancer deaths
and registrations include construction, metal working, mining,
land transport, roofing and road repair/construction, printing,
farming, some service industry sectors in particular personal
and household services and wholesale and retail trades,
restaurants and hotels and manufacture of machinery,
transport equipment, non-ferrous metals and metal products,
and chemicals.
Policy implicat ions
c Estimates for all but leukaemia are greater than those currently
used in UK health and safety strategy planning and contrast
with small numbers from occupational accidents.
c Carcinogenic agents, occupations and industrial areas are
highlighted for prioritisation of risk reduction strategies.
c Past high exposures will continue to give substantial numbers
in the near future and, although levels of many exposures have
reduced, recent measurements of others show continuing high
levels which must be addressed.
other non-carcinogenic agents. Other carcinogens such as
naturally occurring radon could also easily be eliminated from
workplaces. However, the long latency of some cancers means
that numbers of deaths and registrations due to past high
exposures will continue to be substantial in the near future
(particularly asbestos-related cancers).
For some carcinogenic agents exposures remain high. For
example, recent wood dust measurements have shown con-
tinuing high exposures.76 Although some hazards, such as
certain solvents in paints, may have been removed from
occupations with multiple exposures, the potential for exposure
to other hazards remains, for example, silica exposure in the
construction industry, in which the number of employees is
increasing. Studies in the Dutch construction industry sug-
gested that over half of the full-shift respirable quartz dust
measurements were above the Dutch Occupational Exposure
Limit with exposure being highly variable from day to day and
between jobs and tasks.77 In addition there will be considerable
numbers of workers exposed at low levels and risk to some
carcinogens that may contribute substantially to both high AFs
and numbers.
Future work will address estimation of the current burden
due to occupational exposures for the remaining cancers, the use
Downloaded from oem.bmj.com on 18 November 2008
801 Occup Environ Med 2008;65:789–800. doi:1 0.11 36/oem.2007.03 7002
of other measures such as years of life lost and Disability-
Adjusted Life Years, together with development of appropriate
methodology for predicting future estimates of the occupational
cancers due to more recent exposures and for exploring the
sensitivity of the estimates to sources of uncertainty and bias.
In summary, this project is the first to quantify in detail the
burden of cancer due to occupation specifically for GB. An up-
to-date estimation of the current burden of six cancers due to
past occupational exposures has been carried out using a robust
and transparent methodology. On balance the estimates are
likely to be conservative estimates of the true burden. The
results highlight specific carcinogenic agents and the occupa-
tional circumstances and industrial areas where exposures to
these agents occur, and should facilitate prioritisation of risk
reduction strategies.
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STATISTICAL APPENDIX
Formulae used in the estimation of attributable fraction
1. Levin’s equation
AF = Pr(E)*(RR-1 )/{ 1+Pr(E)*(RR-1 )}
Where RR = relative risk, Pr(E) = proportion of the population exposed
2. Miett inen’s equation
AF = Pr(E|D)*(RR-1)/RR
Where Pr(E | D) = proportion of cases exposed (E = exposed, D = case)
3. Turnover equation to estimate numbers ever employed during the REP
Where Ne(REP) = numbers ever employed in the REP
n0 = numbers employed in the exposed job/industry at a mid-point in the REP
TO = staff turnover per year
R = retirement age (65 for men, 60 for women)
l(adj15)i = the proportion of survivors to age i of those alive at age 15 (from GB life
tables)
a to b = age range achieved by the original cohort members by the target year
(2004) (eg 65 to 100 for the solid tumour REP)
c to d = age range achieved by the turnover recruited cohort members by the target
year (25 to 64 for the solid tumour REP)
age(u) and age(l) = upper and lower recruitment age limits (24 and 15)
The derivation and assumptions underlying this formula are described in the
methodology technical report (http://www.hse.gov.uk/research/rrhtm/rr595.htm). The
equation can be represented as a single factor acting as a multiplier for n0, calculated
by setting n0 to 1 in the above equation, so that the factor varies only with TO (see
table A1).
4. Equation to estimate the proportion of the population exposed
Pr(E) = Ne(REP)/Np(REP)
where Np(REP) = numbers ever of working age during the REP from population
estimates for the relevant age cohorts in the target year (2004)
5. Equation for combining AFs where exposed populations overlap but are independent
and risk estimates are assumed to be multiplicative
AFoverall = 1- Pk(1 -AFk) for the k exposures in the set
Table A1 Employment level adjustment and turnover factors used in the calculation of attributable fraction
Main indus try sec tor
Adjustment factor for
change in employment
levels* Turnover peryear (%)
Equivalent turnover factor to
apply to poin t est imate of
numbers exposed {
Men Agriculture, hunting and
forestry; fishing
1 9 3
Mining and quarrying,
electricity, gas and water;
manufacturing industry
1.4 9 4
Construction 1 13 5
Service industries 0.9 11 4
Total 1 10 4
Women Agriculture, hunting and
forestry; fishing
0.75 10 4
Mining and quarrying,
electricity, gas and water;
manufacturing industry
1.5 14 6
Construction 0.67 16 6
Service industries 0.8 15 6
Total 0.9 15 6
*Applied to CAREX data only. Exposed numbers are obtained for a mid-point year in the REP where national employment data
sources have been used (the LFS or CoE).
{Based on a 40-year (solid tumour) REP and life expectancy tables.
CoE, Census of Employment; LFS, Labour Force Survey; REP, relevant exposure period.
